HYPERION DEFI, INC. (HYPD) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US30234E2037
HYPERION DEFI, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 813,455.00 USD |
| Gross profit | 510,165.00 USD |
| Operating income | -46.72 m USD |
| EBIT | -44.03 m USD |
| Net income | -45.31 m USD |
| Diluted EPS – continuing operations | -9.40 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About HYPERION DEFI, INC.
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
More stocks
- Harvard Apparatus Regenerative Technology, Inc. (HRGN)
- SAIHEAT Ltd (SAIH)
- Qualisys Holding AB (publ) (QSYS.ST)
- Namib Minerals Ordinary Shares (NAMM)
- Poled (487580.KQ)
- Nyquest Technology Co Ltd (6494.TWO)
- Carbon-Based Technology Inc. (7719.TWO)
- Protia Inc. (303360.KQ)
- VirnetX Holding Corp (VHC)
- Precipio, Inc. (PRPO)
- XTI Aerospace, Inc. (XTIA)
- Cytogen Inc (217330.KQ)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.